FDA Authorizes Extra Covid-19 Vaccine Dose For Those With Weakened Immune Systems

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on pocket
Pocket
Share on whatsapp
WhatsApp
FDA Authorizes Extra Covid-19 Vaccine Dose For Those With Weakened Immune Systems

Topline

The U.S. Food and Drug Administration (FDA) on Thursday night approved a booster dose of the Covid-19 vaccines made by Pfizer and Moderna for people with compromised immune systems, in a move that will likely enhance protection for vulnerable individuals at a time when the more infectious delta variant continues to spread all over the country.

Key Facts

In a late-night announcement, the FDA amended its emergency use authorization (EUA) for the two mRNA vaccines to allow the administration of a third dose to recipients of solid organ transplant or those diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

The FDA’s move comes after few other countries including Israel, France and Germany began administering an additional dose to certain people amid the threat of the more infectious delta variant of the virus.

This is a developing story.

Source link

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on pocket
Pocket
Share on whatsapp
WhatsApp

Related News

Never miss any important news. Subscribe to our newsletter.

Recent News

Editor's Pick